These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2481535)

  • 1. Unrelated donor bone marrow transplantation. Current concepts and future prospects.
    Hows JM
    Beitr Infusionsther; 1989; 24():172-9. PubMed ID: 2481535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unrelated donor marrow transplantation for severe aplastic anaemia.
    Howard MR
    Transfus Sci; 1991; 12(3):123-34. PubMed ID: 10149542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unrelated donor BMT recipients given pretransplant low-dose antithymocyte globulin have outcomes equivalent to matched sibling BMT: a matched pair analysis.
    Duggan P; Booth K; Chaudhry A; Stewart D; Ruether JD; Glück S; Morris D; Brown CB; Herbut B; Coppes M; Anderson R; Wolff J; Egeler M; Desai S; Turner AR; Larratt L; Gyonyor E; Russell JA;
    Bone Marrow Transplant; 2002 Nov; 30(10):681-6. PubMed ID: 12420207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular techniques for typing unrelated marrow donors: potential impact of molecular typing disparity on donor selection.
    Baxter-Lowe LA
    Bone Marrow Transplant; 1994; 14 Suppl 4():S42-50. PubMed ID: 7728125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Allogeneic bone marrow transplantation of unrelated donors; fewer complication, more donors].
    Liem GS; Cornelissen JJ; Oudshoorn M; Sintnicolaas K; Löwenberg B; Hagenbeek A
    Ned Tijdschr Geneeskd; 1997 Aug; 141(32):1553-6. PubMed ID: 9543748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unrelated donor marrow transplantation in childhood: a report from the Associazione Italiana Ematologia e Oncologia Pediatrica (AIEOP) and the Gruppo Italiano per il Trapianto Midollo Osseo (GITMO).
    Dini G; Cancedda R; Giorgiani G; Porta F; Messina C; Uderzo C; Pession A; Fagioli F; La Nasa G; Arcese W; Pollichieni S; Zecca M; Lanino E; Mazzolari E; Cesaro S; Balduzzi A; Rondelli R; Vassallo E; Cappelli B; Locatelli F;
    Haematologica; 2002 Aug; 87(8 Suppl):51-7. PubMed ID: 12412391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic bone marrow transplantation in the treatment of hematologic diseases.
    Yee GC; McGuire TR
    Clin Pharm; 1985; 4(2):149-60. PubMed ID: 3886273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second allogeneic bone marrow transplants from unrelated donors for graft failure following initial unrelated donor bone marrow transplantation.
    Grandage VL; Cornish JM; Pamphilon DH; Potter MN; Steward CG; Oakhill A; Marks DI
    Bone Marrow Transplant; 1998 Apr; 21(7):687-90. PubMed ID: 9578308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT).
    Bishara A; Amar A; Brautbar C; Condiotti R; Lazarovitz V; Nagler A
    Exp Hematol; 1995 Dec; 23(14):1667-75. PubMed ID: 8542963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and pharmacological risk factors for acute graft-versus-host disease after paediatric bone marrow transplantation from matched-sibling or unrelated donors.
    Martin P; Bleyzac N; Souillet G; Galambrun C; Bertrand Y; Maire PH; Jelliffe RW; Aulagner G
    Bone Marrow Transplant; 2003 Nov; 32(9):881-7. PubMed ID: 14561988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A survey of use of unrelated volunteer donor bone marrow transplantation at 46 centres worldwide, 1989-93. International Marrow Unrelated Search and Transplant (IMUST) Study.
    Downie TR; Hows JM; Gore SM; Bradley BA; Howard MR
    Bone Marrow Transplant; 1995 Apr; 15(4):499-503. PubMed ID: 7655372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric bone marrow transplantation: current progress and future prospects.
    Sondel PM; Trigg ME; Hong R; Finlay JL; Bozdech MJ
    Pediatrics; 1983 Dec; 72(6):818-23. PubMed ID: 6359048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of the serotherapy regimen used and the marrow cell dose received on rejection, graft-versus-host disease and outcome following unrelated donor bone marrow transplantation for leukaemia.
    Byrne JL; Stainer C; Cull G; Haynes AP; Bessell EM; Hale G; Waldmann H; Russell NH
    Bone Marrow Transplant; 2000 Feb; 25(4):411-7. PubMed ID: 10723585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term results of allogeneic bone marrow transplantation for 108 adult patients with acute lymphoblastic leukemia: favorable outcome with BMT at first remission and HLA-matched unrelated donor.
    Chim CS; Lie AK; Liang R; Au WY; Kwong YL
    Bone Marrow Transplant; 2007 Aug; 40(4):339-47. PubMed ID: 17572712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow transplantation for severe aplastic anemia from donors other than HLA identical siblings: a report of the BMT Working Party.
    Bacigalupo A; Hows J; Gordon-Smith EC; Gluckman E; Van Lint MT; Congiu M; James DC; Barrett AJ; Gmur J; De Planque MM
    Bone Marrow Transplant; 1988 Nov; 3(6):531-5. PubMed ID: 3063321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic graft-versus-host disease in children and adolescents after bone marrow transplantation from HLA-matched donors.
    Yumura-Yagi K; Inoue M; Sakata N; Okamura T; Yasui M; Nakano T; Nomura K; Nakano T; Park DY; Endo C; Nishiuchi R; Sawada A; Matsuda Y; Oota H; Yoshimoto T; Kawa-Ha K
    Int J Hematol; 2000 Apr; 71(3):278-82. PubMed ID: 10846836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD8+ T-cell-depleted, matched unrelated donor, allogeneic bone marrow transplantation for advanced AML using busulfan-based preparative regimens.
    Kalaycio M; Rybicki L; Pohlman B; Sobecks R; Ball E; Cook D; Andresen S; Kuczkowski E; Bolwell B
    Bone Marrow Transplant; 2005 Feb; 35(3):247-52. PubMed ID: 15580282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term observation after simultaneous lung and intra-bone marrow-bone marrow transplantation.
    Kaneda H; Adachi Y; Saito Y; Ikebukuro K; Machida H; Suzuki Y; Minamino K; Zhang Y; Iwasaki M; Nakano K; Koike Y; Wang J; Imamura H; Ikehara S
    J Heart Lung Transplant; 2005 Sep; 24(9):1415-23. PubMed ID: 16143265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bone marrow transplantation].
    Speck B; Gratwohl A; Tichelli A; Nissen C
    Schweiz Med Wochenschr; 1995 Aug; 125(33):1515-32. PubMed ID: 7676241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.